Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ADO-TRASTUZUMAB EMTANSINE Cause Panic attack? 18 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 18 reports of Panic attack have been filed in association with ADO-TRASTUZUMAB EMTANSINE. This represents 0.2% of all adverse event reports for ADO-TRASTUZUMAB EMTANSINE.

18
Reports of Panic attack with ADO-TRASTUZUMAB EMTANSINE
0.2%
of all ADO-TRASTUZUMAB EMTANSINE reports
10
Deaths
17
Hospitalizations

How Dangerous Is Panic attack From ADO-TRASTUZUMAB EMTANSINE?

Of the 18 reports, 10 (55.6%) resulted in death, 17 (94.4%) required hospitalization, and 1 (5.6%) were considered life-threatening.

Is Panic attack Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ADO-TRASTUZUMAB EMTANSINE. However, 18 reports have been filed with the FAERS database.

What Other Side Effects Does ADO-TRASTUZUMAB EMTANSINE Cause?

Nausea (780) Fatigue (774) Disease progression (750) Diarrhoea (654) Off label use (630) Thrombocytopenia (519) Death (509) Neuropathy peripheral (506) Headache (465) Platelet count decreased (453)

What Other Drugs Cause Panic attack?

CLONAZEPAM (738) CIPROFLOXACIN (689) ADALIMUMAB (637) SODIUM OXYBATE (618) SERTRALINE (568) DULOXETINE (545) LEVONORGESTREL (502) PREGABALIN (499) PAROXETINE (441) OXYCODONE (422)

Which ADO-TRASTUZUMAB EMTANSINE Alternatives Have Lower Panic attack Risk?

ADO-TRASTUZUMAB EMTANSINE vs ADRIAMYCIN ADO-TRASTUZUMAB EMTANSINE vs ADUCANUMAB ADO-TRASTUZUMAB EMTANSINE vs ADUCANUMAB-AVWA ADO-TRASTUZUMAB EMTANSINE vs ADVAIR ADO-TRASTUZUMAB EMTANSINE vs ADVAIR HFA

Related Pages

ADO-TRASTUZUMAB EMTANSINE Full Profile All Panic attack Reports All Drugs Causing Panic attack ADO-TRASTUZUMAB EMTANSINE Demographics